Looked into Aspen a bit today and I think its a very strong...

Looked into Aspen a bit today and I think its a very strong chance of proceeding. GlaxoSmithKline is a key Aspen stakeholder with 19% of the stock and an alliance in Sth Africa. Here they own Panadol and turnover about $1.8 billion in competition with Sigma / Heron. Unlike Sigma GSK are able to turn a healthy profit ...around 100 million last year...so Aspen will know things can be done much better in Aust. and there are many opportunities for them to replicate the mutual back scratching as per Sth Africa.. Can't see the accc getting too concerned given GSK only hold 19% and there are other competitors..but it is something to watch.

Needless to say after joining the dots I bought a few more today! Please dyor and nothing is certain in this climate